ArticleFrontiers in immunology2025

Development and validation of a novel nomogram for predicting outcomes in advanced lung cancer patients treated beyond progression with immune checkpoint inhibitors.

Tianwei Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.